What diagnostic workup should be performed for a patient presenting with simultaneous hematospermia (blood in semen) and hematuria (blood in urine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Workup for Simultaneous Hematospermia and Hematuria

When a patient presents with both blood in semen and blood in urine together, this represents symptomatic hematospermia requiring comprehensive imaging evaluation, with MRI pelvis (with or without contrast) as the preferred initial imaging modality, combined with urinalysis, urine culture, and cystoscopy to exclude malignancy and identify treatable causes.

Initial Clinical Assessment

The combination of hematospermia with hematuria is clinically significant and warrants thorough investigation, as this presentation suggests pathology affecting both the urinary and reproductive tracts 1. This differs from isolated hematospermia, which is typically benign and often requires only reassurance.

Key Historical Elements to Obtain:

  • Age (malignancy risk increases significantly >40 years, particularly >35 years for hematuria) 2, 3
  • Smoking history and occupational chemical exposures 2
  • Associated symptoms: fever, pain, dysuria, irritative voiding symptoms 1
  • History of trauma to the pelvis or genitourinary tract 1
  • Prior urologic disease, pelvic irradiation, or chronic UTIs 2
  • Timing: Does hematuria occur specifically after ejaculation or erection? 4

Essential Laboratory Workup:

  • Urinalysis with microscopy (properly collected, non-contaminated specimen) 2
  • Urine culture before initiating antibiotics if infection suspected 2
  • Prostate-specific antigen (PSA) - significantly elevated in hematospermia with epididymitis 5
  • Serum creatinine to assess renal function 2

Imaging Strategy

Primary Imaging Recommendation

MRI pelvis without and with IV contrast is the most appropriate initial imaging study for this presentation 1. This modality provides:

  • Superior soft tissue resolution for visualizing seminal vesicles, prostate, and ejaculatory ducts
  • Detection of seminal vesicle hemorrhage (found in 86.2% of patients with recurrent hematospermia) 1
  • Identification of masses, cysts, abscesses, and vascular anomalies
  • Evaluation of prostate pathology including cancer

Alternative if MRI unavailable or contraindicated: CT urography (CTU) without and with IV contrast provides comprehensive evaluation of both upper and lower urinary tracts plus pelvic organs, though with inferior soft tissue detail compared to MRI 1, 2.

Rationale for Imaging Choice

The 2025 ACR Appropriateness Criteria specifically state that when hematospermia presents with associated hematuria, imaging is useful in confirming possible pathologies including urinary tract stones, masses, prostatic abscess, and congenital anomalies 1. MRI's superior tissue characterization makes it ideal for detecting:

  • Seminal vesicle pathology (hemorrhage, cysts, calculi)
  • Prostatic lesions requiring multiparametric evaluation
  • Ejaculatory duct obstruction
  • Vascular malformations
  • Blood products (readily visible even without contrast) 1

Secondary Imaging Considerations

Transrectal ultrasound (TRUS) can be considered as an adjunct, particularly for:

  • Guiding seminal vesicle aspiration to confirm bleeding source 6
  • Evaluating seminal vesicle cysts and calculi
  • Directing prostate biopsy if indicated 1

However, TRUS has limited field of view and is less commonly used as initial imaging in the United States 1.

Cystoscopy

Cystoscopy is mandatory in this clinical scenario 2. The presence of hematuria, particularly when combined with hematospermia, requires direct visualization to exclude:

  • Bladder malignancy (gross hematuria has 30-40% association with malignancy) 2
  • Posterior urethral hemangioma (a frequently missed cause of combined hematospermia and post-ejaculation hematuria) 4
  • Ectopic prostatic tissue in the prostatic urethra 6
  • Prostatic urethral lesions

Critical Technical Point for Cystoscopy

Perform cystoscopy immediately after ejaculation or erection when possible, with reduced irrigant flow, to enhance detection of posterior urethral hemangiomas - a commonly overlooked cause of this presentation 4. These lesions typically appear as 5mm solitary sessile varicosities on the membranous urethra between the verumontanum and external sphincter.

Age-Stratified Approach

Patients ≥40 Years Old:

  • Full workup mandatory due to 7.2% prostate cancer detection rate in hematospermia patients this age 3
  • PSA testing essential
  • Consider multiparametric MRI with dedicated prostate protocol if PSA elevated or clinical suspicion 1
  • Cystoscopy non-negotiable given malignancy risk

Patients <40 Years Old:

  • Still requires imaging and cystoscopy given symptomatic presentation with hematuria
  • Cancer risk lower (0.01% in isolated hematospermia) but not zero 7
  • Focus on infectious, inflammatory, and vascular etiologies

Common Pitfalls to Avoid

  1. Do not dismiss as benign isolated hematospermia - the presence of concomitant hematuria changes risk stratification entirely 1

  2. Do not delay workup for anticoagulation - anticoagulant use does not alter the need for evaluation 2

  3. Do not miss posterior urethral hemangioma - this requires specific cystoscopic technique (post-ejaculation timing, reduced flow) and is more common than historically recognized 4

  4. Do not skip imaging in favor of observation - symptomatic hematospermia with hematuria warrants imaging regardless of age 1

  5. Do not obtain CT without urographic protocol - if choosing CT over MRI, ensure proper CTU technique with non-contrast, nephrographic, and excretory phases 2

Special Consideration: Arterial Bleeding

In cases of intractable hematospermia with persistent hematuria unresponsive to treatment, consider pelvic angiography 8. Arterial bleeding (typically from internal pudendal artery) can be detected and treated with transcatheter arterial embolization without causing impotence, though long-term follow-up is needed for potential recurrence from contralateral flow 8.

Infectious Workup

If clinical features suggest infection (fever, leukocytosis, scrotal pain):

  • Obtain urine culture before antibiotics 2
  • Consider testing for sexually transmitted infections including Chlamydia trachomatis and Escherichia coli 5
  • Note that hematospermia may precede scrotal symptoms of epididymitis by 24 hours 5
  • Follow-up semen analysis at 14 days may still show hematospermia with leukocytospermia 5

Related Questions

What is the appropriate initial evaluation and management for a 21‑year‑old man presenting with hematospermia and hematuria?
Can hematospermia be an early sign of prostate cancer?
In a 33-year-old patient with 11–30 red blood cells per high-power field on urinalysis (microscopic hematuria), no evidence of infection, and a normal CT urogram, should I refer them to urology?
How should I manage a patient with dysuria, microscopic hematuria (45‑50 red blood cells per high-power field), mild pyuria (2‑4 white blood cells per high-power field), sterile urine culture, and no prior antibiotic therapy?
How should a stable 13-year-old girl with headache, normal blood pressure, normal systemic examination, isolated microscopic hematuria (urine dipstick blood ++) with negative urine culture, and normal complete blood count and renal function be managed?
What are the differential diagnoses for facial twitching?
What are the differences between Mucinex DM (guaifenesin and dextromethorphan) and generic guaifenesin/dextromethorphan (guaifenesin DM)?
In a patient who declined proton pump inhibitors (PPIs), is currently taking famotidine 20 mg twice daily and sucralfate, and had a mild COVID‑19 infection one month ago treated with Paxlovid (nirmatrelvir/ritonavir), what is the appropriate management for their reflux symptoms?
For a persistent itchy, tender bump in the gluteal fold at the panty line, is bacitracin or mupirocin the preferred topical treatment?
Which guideline or article provides evidence that lactulose enemas are an adequate preventive treatment for hepatic encephalopathy?
What are the long‑term adverse effects of nightly trazodone 100 mg in a patient with depression who has recently increased sertraline to 100 mg and has unstable anxiety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.